Found: 58
Select item for more details and to access through your institution.
Liver cancer in ovo models for preclinical testing.
- Published in:
- FASEB Journal, 2024, v. 38, n. 17, p. 1, doi. 10.1096/fj.202401416R
- By:
- Publication type:
- Article
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 3, p. 268, doi. 10.1159/000522418
- By:
- Publication type:
- Article
Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 13, p. N.PAG, doi. 10.3390/cells11132051
- By:
- Publication type:
- Article
Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2671, doi. 10.3390/cells10102671
- By:
- Publication type:
- Article
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40328-4
- By:
- Publication type:
- Article
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: Are we only looking at tumor necrosis?
- Published in:
- Journal of Magnetic Resonance Imaging, 2014, v. 39, n. 2, p. 317, doi. 10.1002/jmri.24172
- By:
- Publication type:
- Article
Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 12, p. 1, doi. 10.1002/cti2.1208
- By:
- Publication type:
- Article
Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient.
- Published in:
- 2017
- By:
- Publication type:
- case study
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 16206, doi. 10.3390/ijms232416206
- By:
- Publication type:
- Article
Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1794, doi. 10.3390/ijms22041794
- By:
- Publication type:
- Article
Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5250, doi. 10.3390/ijms21155250
- By:
- Publication type:
- Article
Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4398, doi. 10.3390/ijms21124398
- By:
- Publication type:
- Article
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
- By:
- Publication type:
- Article
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
- By:
- Publication type:
- Article
Recipient age influences survival after liver transplant: Results of the French national cohort 2007–2017.
- Published in:
- Liver International, 2024, v. 44, n. 6, p. 1396, doi. 10.1111/liv.15867
- By:
- Publication type:
- Article
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 546, doi. 10.1111/liv.15504
- By:
- Publication type:
- Article
Alcohol‐related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1638, doi. 10.1111/liv.15256
- By:
- Publication type:
- Article
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1869, doi. 10.1111/liv.13491
- By:
- Publication type:
- Article
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.
- Published in:
- Liver International, 2017, v. 37, n. 5, p. 717, doi. 10.1111/liv.13388
- By:
- Publication type:
- Article
Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17<sup>+</sup> neutrophils.
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1116, doi. 10.1111/liv.13060
- By:
- Publication type:
- Article
Liver-infiltrating CD8<sup>+</sup> lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
- Published in:
- Liver International, 2016, v. 36, n. 3, p. 434, doi. 10.1111/liv.12927
- By:
- Publication type:
- Article
Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00112
- By:
- Publication type:
- Article
Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231189425
- By:
- Publication type:
- Article
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.
- Published in:
- 2014
- By:
- Publication type:
- journal article
ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2014, v. 464, n. 1, p. 53, doi. 10.1007/s00428-013-1515-0
- By:
- Publication type:
- Article
Enjeux actuels autour des thérapies combinées de carcinome hépatocellulaire : immunomodulations et vaccins.
- Published in:
- Revue Immunite & Cancer, 2024, v. 8, n. 2, p. 65
- By:
- Publication type:
- Article
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients.
- Published in:
- Biomarker Research, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40364-024-00583-z
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Sex Differences in Spontaneous Degranulation Activity of Intrahepatic Natural Killer Cells during Chronic Hepatitis B: Association with Estradiol Levels.
- Published in:
- Mediators of Inflammation, 2017, p. 1, doi. 10.1155/2017/3214917
- By:
- Publication type:
- Article
Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
- Published in:
- Abdominal Radiology, 2018, v. 43, n. 7, p. 1670, doi. 10.1007/s00261-017-1377-z
- By:
- Publication type:
- Article
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320942042
- By:
- Publication type:
- Article
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition.
- Published in:
- Therapeutic Advances in Chronic Disease, 2020, v. 11, p. 1, doi. 10.1177/2040622320942042
- By:
- Publication type:
- Article
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general population.
- Published in:
- Acta Radiologica, 2023, v. 64, n. 5, p. 1730, doi. 10.1177/02841851221138519
- By:
- Publication type:
- Article
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and 18F-FDG PET/CT in patients on waitinglist for liver transplantation.
- Published in:
- Cancer Imaging, 2016, v. 16, p. 1, doi. 10.1186/s40644-016-0062-8
- By:
- Publication type:
- Article
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immunologie dans le carcinome hépatocellulaire : bases physiopathologiques et cibles thérapeutiques.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, p. 26, doi. 10.1684/hpg.2020.1947
- By:
- Publication type:
- Article
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 3, p. 921, doi. 10.1007/s00259-022-06002-5
- By:
- Publication type:
- Article
Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review.
- Published in:
- Biomedicines, 2021, v. 9, n. 4, p. 378, doi. 10.3390/biomedicines9040378
- By:
- Publication type:
- Article
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1807, doi. 10.1111/bcp.14283
- By:
- Publication type:
- Article
Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1634, doi. 10.3390/cancers14071634
- By:
- Publication type:
- Article
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4981, doi. 10.3390/cancers13194981
- By:
- Publication type:
- Article
Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2480, doi. 10.3390/cancers13102480
- By:
- Publication type:
- Article
Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2121, doi. 10.3390/cancers13092121
- By:
- Publication type:
- Article
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 812, doi. 10.3390/cancers13040812
- By:
- Publication type:
- Article
Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3820, doi. 10.3390/cancers12123820
- By:
- Publication type:
- Article